| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
| 03/20/2001 | US6204019 Sec A2 from Streptococcus pneumoniae |
| 03/20/2001 | US6204018 66 kDa antigen from Borrelia |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203799 Cholera vaccines; deleted mutant strain |
| 03/20/2001 | US6203798 Lyme disease diagnosis and vaccines; genetic engineering |
| 03/20/2001 | CA2071529C Diaromatic substituted anti-aids compounds |
| 03/20/2001 | CA2007761C Novel benzo[b][1,8]naphtyridine derivatives and process for preparing the same |
| 03/20/2001 | CA2007760C Novel benzo[b][1,8]naphtyridine derivatives; process for preparing the same and compositions containing them |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018227A1 Novel compound f-15078 |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018038A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018015A1 Oligonucleotide n3'→p5' thiophosphoramidates: their synthesis and use |
| 03/15/2001 | WO2001018013A1 Prodrugs for liver specific drug delivery |
| 03/15/2001 | WO2001018006A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | WO2001018005A1 Process for the preparation of benzoxazine derivatives and intermediates therefor |
| 03/15/2001 | WO2001018003A1 Carbocyclic nucleosides and process for obtaining such |
| 03/15/2001 | WO2001018001A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | WO2001017997A1 Substituted diazaanthracene compounds having pharmaceutical utility |
| 03/15/2001 | WO2001017991A1 Quinolinecarboxylic acid derivative or its salt |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017968A1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 03/15/2001 | WO2001017955A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 03/15/2001 | WO2001017953A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017553A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 03/15/2001 | WO2001017552A1 Kaposi's sarcoma-associated herpesvirus ks-sm gene product and uses thereof |
| 03/15/2001 | WO2001017551A2 Combined vaccine compositions |
| 03/15/2001 | WO2001017550A2 Vaccine against hbv and hpv |
| 03/15/2001 | WO2001017548A2 Use of natriuretic peptides as antibiotically effective substances for treating bacterial infections |
| 03/15/2001 | WO2001017546A1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 03/15/2001 | WO2001017539A1 Herbal compositions for itchy or infected skin |
| 03/15/2001 | WO2001017537A2 Methods and compositions for reducing immune response |
| 03/15/2001 | WO2001017535A2 Enriched fraction from a porcine liver extract for treating human diseases |
| 03/15/2001 | WO2001017504A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000061604A3 Pharmaceutical compounds |
| 03/15/2001 | WO2000059469A3 Endodontic fibers and methods of use therefor |
| 03/15/2001 | WO2000057854A3 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances |
| 03/15/2001 | WO2000051613A8 Upper hitch link |
| 03/15/2001 | WO2000047196A3 Use of statins for treating viral infections |
| 03/15/2001 | WO2000044358A3 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections |
| 03/15/2001 | WO2000010562A8 Physically stable and x-ray amorphous form of hydrochloride ranitidine having an increased anti-ulcer activity and method for producing the same |
| 03/15/2001 | WO1999065870A3 Sulfonamide inhibitors of aspartyl protease |
| 03/15/2001 | US20010000039 A compound having a sulfur-nitric oxide group (S-N=O) group as well as a free alcohol or thiol with a half-life of over twelve hours, e.g. S-nitroso-N-acetylpenicillamine; catheter coatings; surface sterilization |
| 03/15/2001 | DE19943508A1 3-Vinylpyrol-Derivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel 3 Vinylpyrol derivatives, processes for their preparation and their use as medicaments |
| 03/15/2001 | DE19942230A1 Verfahren zur Anwendung natriuretischer Peptide als antibiotisch wirksame Substanzen zur Behandlung von bakteriellen Infektionen Method of using natriuretic peptides as antibiotic substances for the treatment of bacterial infections |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384151A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384051A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | CA2383980A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2383759A1 Quinolinecarboxylic acid derivative or its salt |
| 03/15/2001 | CA2383758A1 Novel compound f-15078 |
| 03/15/2001 | CA2383086A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2382138A1 Methods and compositions for reducing immune response |
| 03/15/2001 | CA2379532A1 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | CA2349451A1 Substituted diazaanthracene compounds having pharmaceutical utility |
| 03/14/2001 | EP1083232A1 Transfer of mRNA using polycationic compounds |
| 03/14/2001 | EP1083230A1 Viral replicons and viruses dependent on inducing agents |
| 03/14/2001 | EP1083175A2 Triazole derivatives having antifungal activity |
| 03/14/2001 | EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 03/14/2001 | EP1082965A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 03/14/2001 | EP1082962A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZO C ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-$g(k)B |
| 03/14/2001 | EP1082875A1 Improved brush block housing for propeller deicing system |
| 03/14/2001 | EP1082462A1 Identification of molecular interaction sites in rna for novel drug discovery |
| 03/14/2001 | EP1082435A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082422A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation |
| 03/14/2001 | EP1082342A2 Vaccine for pseudomonas aeruginosa |
| 03/14/2001 | EP1082326A1 Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 03/14/2001 | EP1082325A1 Naphthosulfamylmethyl penem antibacterials |
| 03/14/2001 | EP1082323A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082322A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082320A1 Novel substituted imidazole compounds |
| 03/14/2001 | EP1082300A1 3-[(1'-n-methylamino)ethyl-n-benzyl]pyrrolidine monomethanesulfonate |